FOLH1 and cancer: The findings from the current investigation also highlights the potential utility of pet dogs with naturally occurring cancers to serve as a pre-clinical model for PSMA-targeting strategies that can aid disease diagnosis and selective payload delivery of anticancer drugs, small molecule inhibitors, or radionuclides.